REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM NEW
Total 13F shares
23,064,442
Share change
-4,222,724
Total reported value
$18,736,000
Put/Call ratio
92%
Price per share
$0.81
Number of holders
43
Value change
-$7,718,708
Number of buys
26
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q2 2021

As of 30 Jun 2021, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,064,442 shares. The largest 10 holders included NEA Management Company, LLC, VANGUARD GROUP INC, Endurant Capital Management LP, VICTORY CAPITAL MANAGEMENT INC, Sarissa Capital Management LP, Asymmetry Capital Management, L.P., Ikarian Capital, LLC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.